Metabolism of hemoglobin-vesicles (artificial oxygen carriers) and their influence on organ functions in a rat model
Phospholipid vesicles encapsulating Hb (Hb-vesicles: HbV) have been developed for use as artificial O 2 carriers (250 nm φ). As one of the safety evaluations, we analyzed the influence of HbV on the organ functions by laboratory tests of plasma on a total of 29 analytes. The HbV suspension ([Hb]=10...
Gespeichert in:
Veröffentlicht in: | Biomaterials 2004-08, Vol.25 (18), p.4317-4325 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 4325 |
---|---|
container_issue | 18 |
container_start_page | 4317 |
container_title | Biomaterials |
container_volume | 25 |
creator | Sakai, Hiromi Horinouchi, Hirohisa Masada, Yohei Takeoka, Shinji Ikeda, Eiji Takaori, Masuhiko Kobayashi, Koichi Tsuchida, Eishun |
description | Phospholipid vesicles encapsulating Hb (Hb-vesicles: HbV) have been developed for use as artificial O
2 carriers (250
nm
φ). As one of the safety evaluations, we analyzed the influence of HbV on the organ functions by laboratory tests of plasma on a total of 29 analytes. The HbV suspension ([Hb]=10
g/dl) was intravenously infused into male Wistar rats (20
ml/kg; whole blood = 56
ml/kg). The blood was withdrawn at 8
h, and 1, 2, 3, and 7 days after infusion, and the plasma was ultracentrifuged to remove HbV in order to avoid its interference effect on the analytes. Enzyme concentrations, AST, ALT, ALP, and LAP showed significant, but minor changes, and did not show a sign of a deteriorative damage to the liver that was one of the main organs for the HbV entrapment and the succeeding metabolism. The amylase and lipase activities showed reversible changes, however, there was no morphological changes in pancreas. Plasma bilirubin and iron did not increase in spite of the fact that a large amount of Hb was metabolized in the macrophages. Cholesterols, phospholipids, and
β-lipoprotein transiently increased showing the maximum at 1 or 2 days, and returned to the control level at 7 days. They should be derived from the membrane components of HbV that are liberated from macrophages entrapping HbV. Together with the previous report of the prompt metabolism of HbV in the reticuloendothelial system by histopathological examination, it can be concluded that HbV infusion transiently modified the values of the analytes without any irreversible damage to the corresponding organs at the bolus infusion rate of 20
ml/kg. |
doi_str_mv | 10.1016/j.biomaterials.2003.11.005 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71764342</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0142961203010706</els_id><sourcerecordid>17819650</sourcerecordid><originalsourceid>FETCH-LOGICAL-c438t-ece7cda33e4cc43ee51dd145f8f74800af71775462e6da4a0bae92807c1f6dc3</originalsourceid><addsrcrecordid>eNqNkc1u3CAURlHVqpmkfYUKdVE1CzuAwcbdRelPKiXqJnuE4TJhZEMKOGrePoxmpHaXrhBwPj50D0IfKWkpof3Frp18XHSB5PWcW0ZI11LaEiJeoQ2Vg2zESMRrtCGUs2bsKTtBpznvSN0Tzt6iEyoI70fGNqjcQtFTnH1ecHT4Hpa4nePkQ_MI2ZsZMv6sU_HOm1qG45-nLQRsdEoeUj7HOlhc7sEn7IObVwgGcAw4pq0O2K3BFB9DrpdY46QLXqKF-R164-rP4f1xPUN337_dXV03N79-_Ly6vGkM72RpwMBgrO464KaeAAhqLeXCSTdwSYh2Ax0GwXsGvdVck0nDyCQZDHW9Nd0Z-nR49iHF3yvkohafDcyzDhDXrGq65x1nL4JMMkGk7F4E6SDp2AtSwS8H0KSYcwKnHpJfdHpSlKi9RLVT_0pUe4mKUlUl1vCHY8s6LWD_Ro_WKvD1AEAd3mMVobLx-9Fbn8AUZaP_n55nStq2vw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17819650</pqid></control><display><type>article</type><title>Metabolism of hemoglobin-vesicles (artificial oxygen carriers) and their influence on organ functions in a rat model</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Sakai, Hiromi ; Horinouchi, Hirohisa ; Masada, Yohei ; Takeoka, Shinji ; Ikeda, Eiji ; Takaori, Masuhiko ; Kobayashi, Koichi ; Tsuchida, Eishun</creator><creatorcontrib>Sakai, Hiromi ; Horinouchi, Hirohisa ; Masada, Yohei ; Takeoka, Shinji ; Ikeda, Eiji ; Takaori, Masuhiko ; Kobayashi, Koichi ; Tsuchida, Eishun</creatorcontrib><description>Phospholipid vesicles encapsulating Hb (Hb-vesicles: HbV) have been developed for use as artificial O
2 carriers (250
nm
φ). As one of the safety evaluations, we analyzed the influence of HbV on the organ functions by laboratory tests of plasma on a total of 29 analytes. The HbV suspension ([Hb]=10
g/dl) was intravenously infused into male Wistar rats (20
ml/kg; whole blood = 56
ml/kg). The blood was withdrawn at 8
h, and 1, 2, 3, and 7 days after infusion, and the plasma was ultracentrifuged to remove HbV in order to avoid its interference effect on the analytes. Enzyme concentrations, AST, ALT, ALP, and LAP showed significant, but minor changes, and did not show a sign of a deteriorative damage to the liver that was one of the main organs for the HbV entrapment and the succeeding metabolism. The amylase and lipase activities showed reversible changes, however, there was no morphological changes in pancreas. Plasma bilirubin and iron did not increase in spite of the fact that a large amount of Hb was metabolized in the macrophages. Cholesterols, phospholipids, and
β-lipoprotein transiently increased showing the maximum at 1 or 2 days, and returned to the control level at 7 days. They should be derived from the membrane components of HbV that are liberated from macrophages entrapping HbV. Together with the previous report of the prompt metabolism of HbV in the reticuloendothelial system by histopathological examination, it can be concluded that HbV infusion transiently modified the values of the analytes without any irreversible damage to the corresponding organs at the bolus infusion rate of 20
ml/kg.</description><identifier>ISSN: 0142-9612</identifier><identifier>EISSN: 1878-5905</identifier><identifier>DOI: 10.1016/j.biomaterials.2003.11.005</identifier><identifier>PMID: 15046922</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Animals ; Biomimetic material ; Blood ; Blood Substitutes - administration & dosage ; Blood Substitutes - chemistry ; Blood Substitutes - pharmacokinetics ; Drug Carriers - administration & dosage ; Drug Carriers - chemistry ; Drug delivery ; Drug Delivery Systems - methods ; Hemoglobins - administration & dosage ; Hemoglobins - chemistry ; Hepatitis B virus ; In vivo test ; Injections, Intravenous ; Liposome ; Liposomes - administration & dosage ; Liposomes - chemistry ; Liposomes - pharmacokinetics ; Liver - drug effects ; Liver - metabolism ; Male ; Metabolic Clearance Rate ; Nanoparticle ; Organ Specificity ; Oxygen - metabolism ; Pancreas - cytology ; Pancreas - drug effects ; Pancreas - metabolism ; Rats ; Rats, Wistar</subject><ispartof>Biomaterials, 2004-08, Vol.25 (18), p.4317-4325</ispartof><rights>2003 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c438t-ece7cda33e4cc43ee51dd145f8f74800af71775462e6da4a0bae92807c1f6dc3</citedby><cites>FETCH-LOGICAL-c438t-ece7cda33e4cc43ee51dd145f8f74800af71775462e6da4a0bae92807c1f6dc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0142961203010706$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15046922$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sakai, Hiromi</creatorcontrib><creatorcontrib>Horinouchi, Hirohisa</creatorcontrib><creatorcontrib>Masada, Yohei</creatorcontrib><creatorcontrib>Takeoka, Shinji</creatorcontrib><creatorcontrib>Ikeda, Eiji</creatorcontrib><creatorcontrib>Takaori, Masuhiko</creatorcontrib><creatorcontrib>Kobayashi, Koichi</creatorcontrib><creatorcontrib>Tsuchida, Eishun</creatorcontrib><title>Metabolism of hemoglobin-vesicles (artificial oxygen carriers) and their influence on organ functions in a rat model</title><title>Biomaterials</title><addtitle>Biomaterials</addtitle><description>Phospholipid vesicles encapsulating Hb (Hb-vesicles: HbV) have been developed for use as artificial O
2 carriers (250
nm
φ). As one of the safety evaluations, we analyzed the influence of HbV on the organ functions by laboratory tests of plasma on a total of 29 analytes. The HbV suspension ([Hb]=10
g/dl) was intravenously infused into male Wistar rats (20
ml/kg; whole blood = 56
ml/kg). The blood was withdrawn at 8
h, and 1, 2, 3, and 7 days after infusion, and the plasma was ultracentrifuged to remove HbV in order to avoid its interference effect on the analytes. Enzyme concentrations, AST, ALT, ALP, and LAP showed significant, but minor changes, and did not show a sign of a deteriorative damage to the liver that was one of the main organs for the HbV entrapment and the succeeding metabolism. The amylase and lipase activities showed reversible changes, however, there was no morphological changes in pancreas. Plasma bilirubin and iron did not increase in spite of the fact that a large amount of Hb was metabolized in the macrophages. Cholesterols, phospholipids, and
β-lipoprotein transiently increased showing the maximum at 1 or 2 days, and returned to the control level at 7 days. They should be derived from the membrane components of HbV that are liberated from macrophages entrapping HbV. Together with the previous report of the prompt metabolism of HbV in the reticuloendothelial system by histopathological examination, it can be concluded that HbV infusion transiently modified the values of the analytes without any irreversible damage to the corresponding organs at the bolus infusion rate of 20
ml/kg.</description><subject>Animals</subject><subject>Biomimetic material</subject><subject>Blood</subject><subject>Blood Substitutes - administration & dosage</subject><subject>Blood Substitutes - chemistry</subject><subject>Blood Substitutes - pharmacokinetics</subject><subject>Drug Carriers - administration & dosage</subject><subject>Drug Carriers - chemistry</subject><subject>Drug delivery</subject><subject>Drug Delivery Systems - methods</subject><subject>Hemoglobins - administration & dosage</subject><subject>Hemoglobins - chemistry</subject><subject>Hepatitis B virus</subject><subject>In vivo test</subject><subject>Injections, Intravenous</subject><subject>Liposome</subject><subject>Liposomes - administration & dosage</subject><subject>Liposomes - chemistry</subject><subject>Liposomes - pharmacokinetics</subject><subject>Liver - drug effects</subject><subject>Liver - metabolism</subject><subject>Male</subject><subject>Metabolic Clearance Rate</subject><subject>Nanoparticle</subject><subject>Organ Specificity</subject><subject>Oxygen - metabolism</subject><subject>Pancreas - cytology</subject><subject>Pancreas - drug effects</subject><subject>Pancreas - metabolism</subject><subject>Rats</subject><subject>Rats, Wistar</subject><issn>0142-9612</issn><issn>1878-5905</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkc1u3CAURlHVqpmkfYUKdVE1CzuAwcbdRelPKiXqJnuE4TJhZEMKOGrePoxmpHaXrhBwPj50D0IfKWkpof3Frp18XHSB5PWcW0ZI11LaEiJeoQ2Vg2zESMRrtCGUs2bsKTtBpznvSN0Tzt6iEyoI70fGNqjcQtFTnH1ecHT4Hpa4nePkQ_MI2ZsZMv6sU_HOm1qG45-nLQRsdEoeUj7HOlhc7sEn7IObVwgGcAw4pq0O2K3BFB9DrpdY46QLXqKF-R164-rP4f1xPUN337_dXV03N79-_Ly6vGkM72RpwMBgrO464KaeAAhqLeXCSTdwSYh2Ax0GwXsGvdVck0nDyCQZDHW9Nd0Z-nR49iHF3yvkohafDcyzDhDXrGq65x1nL4JMMkGk7F4E6SDp2AtSwS8H0KSYcwKnHpJfdHpSlKi9RLVT_0pUe4mKUlUl1vCHY8s6LWD_Ro_WKvD1AEAd3mMVobLx-9Fbn8AUZaP_n55nStq2vw</recordid><startdate>20040801</startdate><enddate>20040801</enddate><creator>Sakai, Hiromi</creator><creator>Horinouchi, Hirohisa</creator><creator>Masada, Yohei</creator><creator>Takeoka, Shinji</creator><creator>Ikeda, Eiji</creator><creator>Takaori, Masuhiko</creator><creator>Kobayashi, Koichi</creator><creator>Tsuchida, Eishun</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>F28</scope><scope>7X8</scope></search><sort><creationdate>20040801</creationdate><title>Metabolism of hemoglobin-vesicles (artificial oxygen carriers) and their influence on organ functions in a rat model</title><author>Sakai, Hiromi ; Horinouchi, Hirohisa ; Masada, Yohei ; Takeoka, Shinji ; Ikeda, Eiji ; Takaori, Masuhiko ; Kobayashi, Koichi ; Tsuchida, Eishun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c438t-ece7cda33e4cc43ee51dd145f8f74800af71775462e6da4a0bae92807c1f6dc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Animals</topic><topic>Biomimetic material</topic><topic>Blood</topic><topic>Blood Substitutes - administration & dosage</topic><topic>Blood Substitutes - chemistry</topic><topic>Blood Substitutes - pharmacokinetics</topic><topic>Drug Carriers - administration & dosage</topic><topic>Drug Carriers - chemistry</topic><topic>Drug delivery</topic><topic>Drug Delivery Systems - methods</topic><topic>Hemoglobins - administration & dosage</topic><topic>Hemoglobins - chemistry</topic><topic>Hepatitis B virus</topic><topic>In vivo test</topic><topic>Injections, Intravenous</topic><topic>Liposome</topic><topic>Liposomes - administration & dosage</topic><topic>Liposomes - chemistry</topic><topic>Liposomes - pharmacokinetics</topic><topic>Liver - drug effects</topic><topic>Liver - metabolism</topic><topic>Male</topic><topic>Metabolic Clearance Rate</topic><topic>Nanoparticle</topic><topic>Organ Specificity</topic><topic>Oxygen - metabolism</topic><topic>Pancreas - cytology</topic><topic>Pancreas - drug effects</topic><topic>Pancreas - metabolism</topic><topic>Rats</topic><topic>Rats, Wistar</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sakai, Hiromi</creatorcontrib><creatorcontrib>Horinouchi, Hirohisa</creatorcontrib><creatorcontrib>Masada, Yohei</creatorcontrib><creatorcontrib>Takeoka, Shinji</creatorcontrib><creatorcontrib>Ikeda, Eiji</creatorcontrib><creatorcontrib>Takaori, Masuhiko</creatorcontrib><creatorcontrib>Kobayashi, Koichi</creatorcontrib><creatorcontrib>Tsuchida, Eishun</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ANTE: Abstracts in New Technology & Engineering</collection><collection>MEDLINE - Academic</collection><jtitle>Biomaterials</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sakai, Hiromi</au><au>Horinouchi, Hirohisa</au><au>Masada, Yohei</au><au>Takeoka, Shinji</au><au>Ikeda, Eiji</au><au>Takaori, Masuhiko</au><au>Kobayashi, Koichi</au><au>Tsuchida, Eishun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Metabolism of hemoglobin-vesicles (artificial oxygen carriers) and their influence on organ functions in a rat model</atitle><jtitle>Biomaterials</jtitle><addtitle>Biomaterials</addtitle><date>2004-08-01</date><risdate>2004</risdate><volume>25</volume><issue>18</issue><spage>4317</spage><epage>4325</epage><pages>4317-4325</pages><issn>0142-9612</issn><eissn>1878-5905</eissn><abstract>Phospholipid vesicles encapsulating Hb (Hb-vesicles: HbV) have been developed for use as artificial O
2 carriers (250
nm
φ). As one of the safety evaluations, we analyzed the influence of HbV on the organ functions by laboratory tests of plasma on a total of 29 analytes. The HbV suspension ([Hb]=10
g/dl) was intravenously infused into male Wistar rats (20
ml/kg; whole blood = 56
ml/kg). The blood was withdrawn at 8
h, and 1, 2, 3, and 7 days after infusion, and the plasma was ultracentrifuged to remove HbV in order to avoid its interference effect on the analytes. Enzyme concentrations, AST, ALT, ALP, and LAP showed significant, but minor changes, and did not show a sign of a deteriorative damage to the liver that was one of the main organs for the HbV entrapment and the succeeding metabolism. The amylase and lipase activities showed reversible changes, however, there was no morphological changes in pancreas. Plasma bilirubin and iron did not increase in spite of the fact that a large amount of Hb was metabolized in the macrophages. Cholesterols, phospholipids, and
β-lipoprotein transiently increased showing the maximum at 1 or 2 days, and returned to the control level at 7 days. They should be derived from the membrane components of HbV that are liberated from macrophages entrapping HbV. Together with the previous report of the prompt metabolism of HbV in the reticuloendothelial system by histopathological examination, it can be concluded that HbV infusion transiently modified the values of the analytes without any irreversible damage to the corresponding organs at the bolus infusion rate of 20
ml/kg.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>15046922</pmid><doi>10.1016/j.biomaterials.2003.11.005</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0142-9612 |
ispartof | Biomaterials, 2004-08, Vol.25 (18), p.4317-4325 |
issn | 0142-9612 1878-5905 |
language | eng |
recordid | cdi_proquest_miscellaneous_71764342 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Animals Biomimetic material Blood Blood Substitutes - administration & dosage Blood Substitutes - chemistry Blood Substitutes - pharmacokinetics Drug Carriers - administration & dosage Drug Carriers - chemistry Drug delivery Drug Delivery Systems - methods Hemoglobins - administration & dosage Hemoglobins - chemistry Hepatitis B virus In vivo test Injections, Intravenous Liposome Liposomes - administration & dosage Liposomes - chemistry Liposomes - pharmacokinetics Liver - drug effects Liver - metabolism Male Metabolic Clearance Rate Nanoparticle Organ Specificity Oxygen - metabolism Pancreas - cytology Pancreas - drug effects Pancreas - metabolism Rats Rats, Wistar |
title | Metabolism of hemoglobin-vesicles (artificial oxygen carriers) and their influence on organ functions in a rat model |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T02%3A09%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Metabolism%20of%20hemoglobin-vesicles%20(artificial%20oxygen%20carriers)%20and%20their%20influence%20on%20organ%20functions%20in%20a%20rat%20model&rft.jtitle=Biomaterials&rft.au=Sakai,%20Hiromi&rft.date=2004-08-01&rft.volume=25&rft.issue=18&rft.spage=4317&rft.epage=4325&rft.pages=4317-4325&rft.issn=0142-9612&rft.eissn=1878-5905&rft_id=info:doi/10.1016/j.biomaterials.2003.11.005&rft_dat=%3Cproquest_cross%3E17819650%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17819650&rft_id=info:pmid/15046922&rft_els_id=S0142961203010706&rfr_iscdi=true |